Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib with Cisplatin and Radiotherapy in Head and Neck Cancer
NCT00410826Phase 2Completed
- Sponsor
- University of Washington
- Start
- Jun 2006
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University of Washington. Started Jun 2006; status: completed.
02
Drugs
erlotinib
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00410826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00410826.